On June 11, 2021, the opening ceremony of Guangzhou Concord Cancer Center (GCCC) was held in the hospital’s Taihe Hall. Professor Qian Chaonan, President of GCCC, Mr. Liang Yerong, General Manager of GCCC, and over 300 hospital employees and online guests witnessed the milestone event.

Guangzhou Concord Cancer Center “Set Sail”

Distinguished by providing proton therapy, GCCC is a tertiary-level cancer hospital of Concord Medical Group, and was developed with guidance from the University of Texas-MD Anderson Cancer Center (US), in addition to cooperation with domestic tier 3 cancer hospitals. The Phase I construction investment of GCCC exceeds 2 billion yuan. Currently it provides comprehensive services to diagnosis and treat cancer.  Its key capabilities include the Varian ProBeam multi-room proton therapy system, multiple linear accelerators, PET / CT, and other high-end medical equipment. It is the first medical institution providing proton therapy in Guangdong-Hong Kong-Macao Greater Bay Area.

Dr. Yang Jianyu, Chairman of Concord Medical Group, spoke to the hospital ideal of "Elevating life, overcoming cancer": GCCC will spare no efforts in shouldering social responsibility and becoming an important supplementary medical force to public hospitals. As an international cancer center specializing in cancer diagnosis and treatment, prevention, research, training, and telemedicine, GCCC will develop the high ground of medical technology in South China.  GCCC will become the most trusted partner of cancer patients.